Quality of Life under Capecitabine (Xeloda®) in Patients with Metastatic Breast Cancer: Data from a German Non-Interventional Surveillance Study.

6. Juni 2014

Müller, V., Fuxius, S., Steffens, C.-C., Lerchenmüller, C., Luhn, B., Vehling-Kaiser, U., Hurst, U., Hahn, L.-J., Soeling, U., Wohlfarth, T., Zaiss, M., 2014.

Oncol Res Treat 37, 6–6. doi:10.1159/000369487

Abstract